Operation Nasal Vaccine—Lightning speed to counter COVID-19
Eric J. Topol, Akiko Iwasaki
Abstract
Given the poor ability of intramuscular mRNA COVID-19 vaccines to induce robust immunity in the respiratory mucosa, a push for a nasal vaccine strategy is needed.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Mucosal immunityImmunityVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyMucous membrane of nose2019-20 coronavirus outbreakMedicineRespiratory systemBiologyImmune systemPathologyInternal medicineInfectious disease (medical specialty)DiseaseOutbreakSARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesVaccine Coverage and Hesitancy